UA77382C2 - Isolated nucleic acid, which codes ligand cd86 of cat, diagnostic oligonucleotide, cloning vector, vaccine for modulation of immune response by cat and methods for induction or inhibition of immunity by cat - Google Patents

Isolated nucleic acid, which codes ligand cd86 of cat, diagnostic oligonucleotide, cloning vector, vaccine for modulation of immune response by cat and methods for induction or inhibition of immunity by cat Download PDF

Info

Publication number
UA77382C2
UA77382C2 UA2000116864A UA2000116864A UA77382C2 UA 77382 C2 UA77382 C2 UA 77382C2 UA 2000116864 A UA2000116864 A UA 2000116864A UA 2000116864 A UA2000116864 A UA 2000116864A UA 77382 C2 UA77382 C2 UA 77382C2
Authority
UA
Ukraine
Prior art keywords
cat
cells
sti
feline
nucleic acid
Prior art date
Application number
UA2000116864A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Shering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shering Plough Ltd filed Critical Shering Plough Ltd
Publication of UA77382C2 publication Critical patent/UA77382C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
UA2000116864A 1998-05-01 1999-04-30 Isolated nucleic acid, which codes ligand cd86 of cat, diagnostic oligonucleotide, cloning vector, vaccine for modulation of immune response by cat and methods for induction or inhibition of immunity by cat UA77382C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7169998A 1998-05-01 1998-05-01
PCT/US1999/009502 WO1999057271A2 (en) 1998-05-01 1999-04-30 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides

Publications (1)

Publication Number Publication Date
UA77382C2 true UA77382C2 (en) 2006-12-15

Family

ID=22102998

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200603428A UA87470C2 (ru) 1998-05-01 1999-04-30 Выделенная нуклеиновая кислота, кодирующая рецептор ctla-4 кошки, и вакцина для модулирования иммунного ответа у кошки
UA2000116864A UA77382C2 (en) 1998-05-01 1999-04-30 Isolated nucleic acid, which codes ligand cd86 of cat, diagnostic oligonucleotide, cloning vector, vaccine for modulation of immune response by cat and methods for induction or inhibition of immunity by cat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200603428A UA87470C2 (ru) 1998-05-01 1999-04-30 Выделенная нуклеиновая кислота, кодирующая рецептор ctla-4 кошки, и вакцина для модулирования иммунного ответа у кошки

Country Status (20)

Country Link
EP (1) EP1073741B1 (de)
JP (3) JP2002513571A (de)
KR (2) KR100869861B1 (de)
AT (1) ATE481485T1 (de)
AU (1) AU4070399A (de)
BR (1) BR9910153A (de)
CA (1) CA2327539A1 (de)
CZ (1) CZ20003935A3 (de)
DE (1) DE69942765D1 (de)
ES (1) ES2352745T3 (de)
HU (1) HUP0102806A3 (de)
IL (4) IL139371A0 (de)
NO (1) NO20005481L (de)
NZ (1) NZ507794A (de)
PL (1) PL199352B1 (de)
RU (2) RU2377302C2 (de)
SK (1) SK16172000A3 (de)
UA (2) UA87470C2 (de)
WO (1) WO1999057271A2 (de)
ZA (1) ZA200006123B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US7183376B2 (en) 2000-06-23 2007-02-27 Maxygen, Inc. Variant B7 co-stimulatory molecules
CA2411828A1 (en) 2000-06-23 2002-01-03 Maxygen, Inc. Novel co-stimulatory molecules
RU2317329C2 (ru) * 2005-05-04 2008-02-20 Дмитрий Валериевич Федосов Пара синтетических олигонуклеотидов-праймеров, используемых для выявления днк провируса лейкоза кошек эндогенного и экзогенного типа, и условия полимеразной цепной реакции с их использованием
AU2013207191B2 (en) * 2012-01-05 2017-10-26 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers
CN110184283A (zh) * 2019-04-30 2019-08-30 吉林农业大学 一种检测虎细小病毒的lamp-lfd试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658669B1 (fr) * 1990-02-20 1992-07-24 Souriau & Cie Connecteur a verrouillage par levier.
DE122007000078I2 (de) * 1991-06-27 2011-01-13 Bristol Myers Squibb Co CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
AU7638894A (en) * 1993-09-03 1995-03-22 Miyuki Azuma B70(b7-2):ctla-4 bonding protein
JP3907698B2 (ja) * 1994-10-03 2007-04-18 アメリカ合衆国 抗原を発現する組み換えウイルスと免疫刺激分子を発現する組み換えウイルスとを含む組成物
JP4025400B2 (ja) * 1997-04-16 2007-12-19 財団法人化学及血清療法研究所 新規免疫制御分子及びその製造方法

Also Published As

Publication number Publication date
IL139371A (en) 2009-08-03
CZ20003935A3 (cs) 2001-12-12
PL199352B1 (pl) 2008-09-30
NO20005481D0 (no) 2000-10-31
IL184202A (en) 2010-11-30
KR20010082542A (ko) 2001-08-30
JP2010252804A (ja) 2010-11-11
ES2352745T3 (es) 2011-02-22
DE69942765D1 (de) 2010-10-28
KR20040053251A (ko) 2004-06-23
HUP0102806A2 (hu) 2001-11-28
RU2005108676A (ru) 2006-09-10
JP2002513571A (ja) 2002-05-14
EP1073741B1 (de) 2010-09-15
IL184201A (en) 2010-11-30
KR100869861B1 (ko) 2008-11-24
NZ507794A (en) 2003-10-31
HK1034537A1 (en) 2001-10-26
UA87470C2 (ru) 2009-07-27
NO20005481L (no) 2000-12-29
WO1999057271A2 (en) 1999-11-11
PL345975A1 (en) 2002-01-14
RU2263145C2 (ru) 2005-10-27
SK16172000A3 (sk) 2002-10-08
AU4070399A (en) 1999-11-23
JP2010104369A (ja) 2010-05-13
BR9910153A (pt) 2001-10-02
WO1999057271A3 (en) 2000-03-02
WO1999057271A9 (en) 2000-04-27
EP1073741A2 (de) 2001-02-07
RU2377302C2 (ru) 2009-12-27
ATE481485T1 (de) 2010-10-15
HUP0102806A3 (en) 2005-12-28
ZA200006123B (en) 2002-01-20
CA2327539A1 (en) 1999-11-11
IL139371A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
Melero et al. Amplification of tumor immunity by gene transfer of the co‐stimulatory 4‐1BB ligand: synergy with the CD28 co‐stimulatory pathway
KR20030028466A (ko) 새로운 수상 세포 상호자극 분자
JP2010252804A (ja) ネコｃｄ８０、ネコｃｄ８６、ネコｃｄ２８およびネコｃｔｌａ−４核酸およびポリペプチド
US8071738B2 (en) Feline CD86 polypeptides and nucleic acids
Erianne et al. B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth
RU2244006C2 (ru) Рекомбинантный вирус, экспрессирующий чужеродную днк, кодирующую кошачий cd80, кошачий ctla-4 или кошачий cd86, и его использование
US20130295133A1 (en) Recombinant virus expressing foreign dna encoding feline cd80, feline cd86, feline cd28, or feline ctla-4 and uses thereof
WO2020071869A1 (ko) 표적 세포 특이적으로 결합하여 다중 면역기능이 강화된 키메라항원 및 이의용도
KR20210084125A (ko) 신규 사이토메갈로바이러스 dna 백신 컨스트럭트 및 그의 용도
AU2007214286B2 (en) Feline CD80, feline CD86, feline CD28 and feline CTLA-4 nucleic acid and polypeptides
WO2002086060A2 (en) Molecular sequence of pig endogenous retrovirus receptors and methods of use
CN116194475A (zh) 对冠状病毒蛋白具有特异性的有蹄类动物源性多克隆免疫球蛋白和其用途
HK1034537B (en) Feline cd86
AU2003271367A1 (en) Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides
Von Beust In vivo priming of bovine T lymphocytes with vaccinia viruses expressing the bovine leukemia virus envelope gene together with bovine interleukin-4 or bovine interleukin-12
MXPA00010618A (en) Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
WO1995024224A1 (en) Murine model for human immunodeficiency virus (hiv) disease